AGIOS PHARMACEUTICALS, INC.: cash_and_restricted_cash

Value{"amount": 88205000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Period (as of 2023-12-31)
Statuscurrent
EntityAGIOS PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001439222-24-000035
Retrieved: 2026-08-19T14:11:29.585785+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001439222/cash-and-restricted-cash/2023-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/e024c71f-3808-4ddb-9623-15f6153a3c97

History